197 related articles for article (PubMed ID: 34566652)
1. Effects of Trandolapril on Structural, Contractile and Electrophysiological Remodeling in Experimental Volume Overload Heart Failure.
Jarkovská D; Miklovič M; Švíglerová J; Červenka L; Škaroupková P; Melenovský V; Štengl M
Front Pharmacol; 2021; 12():729568. PubMed ID: 34566652
[TBL] [Abstract][Full Text] [Related]
2. Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure.
Karram T; Abbasi A; Keidar S; Golomb E; Hochberg I; Winaver J; Hoffman A; Abassi Z
Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1351-8. PubMed ID: 15894569
[TBL] [Abstract][Full Text] [Related]
3. The impact of phosphodiesterase-5 inhibition or angiotensin-converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload.
Tykvartova T; Miklovic M; Kotrc M; Skaroupkova P; Kazdova L; Trnovska J; Skop V; Kolar M; Novotny J; Melenovsky V
Pharmacol Res Perspect; 2024 Feb; 12(1):e1172. PubMed ID: 38284173
[TBL] [Abstract][Full Text] [Related]
4. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
Ruzicka M; Yuan B; Harmsen E; Leenen FH
Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.
Ryan TD; Rothstein EC; Aban I; Tallaj JA; Husain A; Lucchesi PA; Dell'Italia LJ
J Am Coll Cardiol; 2007 Feb; 49(7):811-21. PubMed ID: 17306712
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome profiling highlights the molecular complexity underlying eccentric cardiac hypertrophy.
Barnes J; Pat B; Chen YW; Powell PC; Bradley WE; Zheng J; Karki A; Cui X; Guichard J; Wei CC; Collawn J; Dell'Italia LJ
Ther Adv Cardiovasc Dis; 2014 Jun; 8(3):97-118. PubMed ID: 24692245
[TBL] [Abstract][Full Text] [Related]
7. The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin.
Ruzicka M; Keeley FW; Leenen FH
Circulation; 1994 Oct; 90(4):1989-96. PubMed ID: 7923689
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.
Perry GJ; Mori T; Wei CC; Xu XY; Chen YF; Oparil S; Lucchesi P; Dell'Italia LJ
Circulation; 2001 Feb; 103(7):1012-6. PubMed ID: 11181478
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor antagonism exacerbates cardiac structural and functional remodeling in female rats.
El Hajj MC; Ninh VK; El Hajj EC; Bradley JM; Gardner JD
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H98-H105. PubMed ID: 27769996
[TBL] [Abstract][Full Text] [Related]
10. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.
Ruzicka M; Skarda V; Leenen FH
Circulation; 1995 Dec; 92(12):3568-73. PubMed ID: 8521580
[TBL] [Abstract][Full Text] [Related]
11. The treatment with trandolapril and losartan attenuates pressure and volume overload alternations of cardiac connexin-43 and extracellular matrix in Ren-2 transgenic rats.
Sykora M; Kratky V; Cervenka L; Kopkan L; Tribulova N; Szeiffova Bacova B
Sci Rep; 2023 Nov; 13(1):20923. PubMed ID: 38017033
[TBL] [Abstract][Full Text] [Related]
12. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
Fraccarollo D; Galuppo P; Hildemann S; Christ M; Ertl G; Bauersachs J
J Am Coll Cardiol; 2003 Nov; 42(9):1666-73. PubMed ID: 14607457
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
Lear W; Ruzicka M; Leenen FH
Am J Physiol; 1997 Aug; 273(2 Pt 2):H641-6. PubMed ID: 9277479
[TBL] [Abstract][Full Text] [Related]
14. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy.
Ruzicka M; Leenen FH
Circulation; 1995 Jan; 91(1):16-9. PubMed ID: 7805197
[TBL] [Abstract][Full Text] [Related]
15. Effect of perindopril in rat cardiac volume overload.
Arnal JF; Philippe M; Laboulandine I; Michel JB
Am Heart J; 1993 Sep; 126(3 Pt 2):776-82. PubMed ID: 8395760
[TBL] [Abstract][Full Text] [Related]
16. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure.
Secchi J; Lecaque D; Dunn FW; Jouquey S; Auberval UD; Benzoni F; Sirugue O; Hamon G
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S30-7. PubMed ID: 7527099
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of short-term preload-induced eccentric cardiac hypertrophy.
Mohamed BA; Asif AR; Schnelle M; Qasim M; Khadjeh S; Lbik D; Schott P; Hasenfuss G; Toischer K
J Transl Med; 2016 May; 14(1):149. PubMed ID: 27234427
[TBL] [Abstract][Full Text] [Related]
19. Differential suppression of pressure-overload cardiac and aortic hypertrophy in rats by angiotensin-converting enzyme inhibitors.
Wang DQ; Kakizoe E; Kobayashi Y; Shimoura K; Okunishi H
Jpn J Pharmacol; 1999 Aug; 80(4):333-42. PubMed ID: 10496334
[TBL] [Abstract][Full Text] [Related]
20. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist.
Haddad GE; Blackwell K; Bikhazi A
Can J Physiol Pharmacol; 2003 Feb; 81(2):142-9. PubMed ID: 12710528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
